Background: Survival in follicular lymphoma (FL) is highly variable, even within prognostic groups defined by tumor grade and the Follicular Lymphoma International Prognostic Index. Studies suggest that germline single nucleotide polymorphisms (SNPs) may hold prognostic information but further investigation is needed. Methods: We explored the association between SNPs and FL outcome using two approaches: 1) Two independent genome-wide association studies (GWAS) of similar to 300.000 SNPs followed by a meta-analysis encompassing 586 FL patients diagnosed in Denmark/Sweden 1999-2002 and in the United States 2001-2006; and 2) Investigation of 22 candidate-gene variants previously associated with FL outcome in the Danish/Swedish cohort (N = 373)...
To identify susceptibility loci for non-Hodgkin lymphoma subtypes, we conducted a three-stage genome...
Motivation: Although NHL (non-Hodgkin’s lymphoma) is the fifth leading cause of cancer incidence and...
Though most follicular lymphoma biomarkers rely on tumor features, the host genetic background may a...
Background: Survival in follicular lymphoma (FL) is highly variable, even within prognostic groups d...
Abstract Background B-cell non-Hodgkin lymphoma represents a diverse group of hematological malignan...
Non-Hodgkin lymphoma is a malignancy derived from lymphoid tissues. In Sweden, non-Hodgkin lymphoma ...
International audiencePURPOSE: We performed a multistage genome-wide association study to identify i...
Inherited risk determinants for follicular lymphoma (FL) have recently been described in the immune ...
Genome-wide association studies (GWASs) of follicular lymphoma (FL) have previously identified human...
Follicular lymphoma (FL) is as an indolent neoplasia with median survival measured in decades. Never...
Genome-wide association studies (GWASs) of follicular lymphoma (FL) have previously identified human...
Genome-wide association studies (GWASs) of follicular lymphoma (FL) have previously identified human...
BACKGROUND: Follicular lymphoma is a clinically and genetically heterogeneous disease, but the progn...
Non-Hodgkin lymphoma (NHL) represents a diverse group of hematological malignancies, of which follic...
Genome-wide association studies (GWASs) of follicular lymphoma (FL) have previously identified human...
To identify susceptibility loci for non-Hodgkin lymphoma subtypes, we conducted a three-stage genome...
Motivation: Although NHL (non-Hodgkin’s lymphoma) is the fifth leading cause of cancer incidence and...
Though most follicular lymphoma biomarkers rely on tumor features, the host genetic background may a...
Background: Survival in follicular lymphoma (FL) is highly variable, even within prognostic groups d...
Abstract Background B-cell non-Hodgkin lymphoma represents a diverse group of hematological malignan...
Non-Hodgkin lymphoma is a malignancy derived from lymphoid tissues. In Sweden, non-Hodgkin lymphoma ...
International audiencePURPOSE: We performed a multistage genome-wide association study to identify i...
Inherited risk determinants for follicular lymphoma (FL) have recently been described in the immune ...
Genome-wide association studies (GWASs) of follicular lymphoma (FL) have previously identified human...
Follicular lymphoma (FL) is as an indolent neoplasia with median survival measured in decades. Never...
Genome-wide association studies (GWASs) of follicular lymphoma (FL) have previously identified human...
Genome-wide association studies (GWASs) of follicular lymphoma (FL) have previously identified human...
BACKGROUND: Follicular lymphoma is a clinically and genetically heterogeneous disease, but the progn...
Non-Hodgkin lymphoma (NHL) represents a diverse group of hematological malignancies, of which follic...
Genome-wide association studies (GWASs) of follicular lymphoma (FL) have previously identified human...
To identify susceptibility loci for non-Hodgkin lymphoma subtypes, we conducted a three-stage genome...
Motivation: Although NHL (non-Hodgkin’s lymphoma) is the fifth leading cause of cancer incidence and...
Though most follicular lymphoma biomarkers rely on tumor features, the host genetic background may a...